BCI Breakthrough: A 43-year-old epilepsy patient in China controls speech and actions via brain-computer interface (BCI) technology.
NeuroXess Collaboration: Shanghai-based NeuroXess and Huashan Hospital achieve real-time Chinese speech decoding through BCI.
High Accuracy: The patient achieved 71% accuracy in decoding 142 Chinese syllables within seven days post-surgery.
Clinical Trials: China conducts multiple trials for partially-invasive and invasive BCI technologies, targeting neurological disorders.
NEO Device: Tsinghua University’s partially-invasive BCI device, NEO, plans large-scale trials in 2025 for spinal injury patients.
Government Support: Beijing and Shanghai release action plans to boost BCI development, aiming for breakthroughs by 2027.
Medical Applications: BCI focuses on treating motor and speech dysfunctions, benefiting millions of patients in China.
Ethical Concerns: Experts highlight challenges like privacy risks and ethical handling of brain data in BCI applications.
Public Acceptance: Improving public understanding and regulatory mechanisms is crucial for BCI’s widespread adoption.
Global Leadership: China aims to maintain its leading role in BCI technology, competing with major nations like the US.